Medicines Development for Global Health

Medicines Development for Global Health (MDGH) is a global not-for-profit organisation and registered charity dedicated to the development of medicines for neglected diseases.

MDGH is working to address global health inequities by researching, developing and delivering new and improved medicines to those people who need them the most. Many neglected tropical diseases (NTDs) are primarily endemic in low- to middle-income countries where people and communities are disproportionally disadvantaged by the traditional consideration of market returns on medicines development. The innovative MDGH not-for-profit model is based on pubic health needs in these affected areas rather than commercial opportunity.

Notably, MDGH became the first independent not-for-profit company to achieve FDA approval for a novel medicine when they registered moxidectin in 2018, the first new treatment for river blindness (onchocerciasis) in 20 years.

Visit: medicinesdevelopment.com for more information.

The brief

We were hired in 2020 to work on 4 page brochure design for MDGH and then in 2021 we were engaged to work on a full digital refresh project including:

Digital content writing and copyediting

UX strategy and design, and persona development

Brand update

Website design and development in Webflow CMS

Creation of custom disease illustrations

Development of custom infographics and icon library

In 2022 and 2023 we have been engaged to work on:

Design and development of the MDGH UK

Copyediting and design of the MDGH 2021 Annual Report

50 page pitch deck designed for Atticus Medical (c/o MDGH) in PowerPoint and made up of many highly graphical components

Event signage and print collateral for the American Society of Tropical Medicine & Hygiene (ASTMH) 2022 Annual Meeting

Moxidectin + Onchocerciasis (MOXONC) timeline infographic design

Design and development of the new Philanthropy pages on the MDGH website (Support us and Donate)

How is this ethical?

MDGH adopt a novel approach to developing new treatments for infectious diseases and is doing transformative work to help to elevate the health status of affected communities living in some of the world’s poorest populations – according to the World Health Organization, an estimated two billion people do not have access to even the most basic of essential medicines.

MDGH has been named as one of Fast Company’s ‘World’s Most Innovative Companies’ for 2019, ranked 7th most innovative not-for-profit company. The founder and managing director of MDGH, Mark Sullivan, was also named the 2019 Victorian Australian of the Year for his role in ensuring millions of disadvantaged people have affordable access to the medicines they need.

Working with not-for-profits that are making a real difference in the world is a privilege. EDCo. is proud to support MDGH as their lead design and digital company.